These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4140799)

  • 21. Transplantation immunity evoked by skin homografts and expressed in intact skin.
    Billingham RE
    Adv Biol Skin; 1971; 11():183-98. PubMed ID: 4146273
    [No Abstract]   [Full Text] [Related]  

  • 22. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 23. Lymphocyte receptors for antigen.
    Marchalonis JJ
    J Med; 1974; 5(6):329-67. PubMed ID: 4153398
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.
    Atkinson K; Storb R; Weiden PL; Deeg HJ; Gerhard-Miller L; Thomas ED
    J Immunol; 1980 Apr; 124(4):1808-14. PubMed ID: 6154081
    [No Abstract]   [Full Text] [Related]  

  • 25. The histocompatibility complex of rhesus monkeys. 3. Evidence for a major MLR locus and histocompatibility-linked Ir genes.
    Balner H; Dorf ME; de Groot ML; Benacerraf B
    Transplant Proc; 1973 Dec; 5(4):1555-60. PubMed ID: 4149547
    [No Abstract]   [Full Text] [Related]  

  • 26. Graft-versus-host reactivity of rat T-cell subsets in isolated class I difference.
    Hasegawa T; Yamaguchi A; Li XK; Yokoi Y; Nakamura S; Baba S; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1596-7. PubMed ID: 7725419
    [No Abstract]   [Full Text] [Related]  

  • 27. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of T-cell responses to histocompatibility antigens by BCG pre-treatment.
    Orbach-Arbouys S; Castes M
    Immunology; 1980 Feb; 39(2):263-8. PubMed ID: 6445869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of monoclonal antibodies in hematology].
    Pagnucco G; Bernasconi C
    Riv Emoter Immunoematol; 1984; 31(1):1-35. PubMed ID: 6085185
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell interactions in antibody formation.
    Bell RG
    J Am Vet Med Assoc; 1982 Nov; 181(10):1011-14. PubMed ID: 6184351
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Popliteal lymph node activation in graft-versus-host and host-versus-graft reaction in mice.
    Korcáková L; Hasková V
    Folia Biol (Praha); 1974; 20(6):405-8. PubMed ID: 4154876
    [No Abstract]   [Full Text] [Related]  

  • 35. [Limitations of the nonimmune lymphocyte transfer test as a method of selecting donors for transplantation (a review of the literature)].
    Shereshkov SI
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):47-52. PubMed ID: 4150019
    [No Abstract]   [Full Text] [Related]  

  • 36. Macrophages activation during graft-versus-host reaction.
    Konikovå E
    Neoplasma; 1974; 21(6):645-53. PubMed ID: 4155486
    [No Abstract]   [Full Text] [Related]  

  • 37. Mixed lymphocyte culture and graft-versus-host analyses of organ-grafted rats that defy normal rules for rejection.
    Sorensen SF; Bildsoe P; Simonsen M
    Transplant Proc; 1972 Jun; 4(2):181-7. PubMed ID: 4402432
    [No Abstract]   [Full Text] [Related]  

  • 38. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions.
    Davignon D; Martz E; Reynolds T; Kürzinger K; Springer TA
    J Immunol; 1981 Aug; 127(2):590-5. PubMed ID: 6166678
    [No Abstract]   [Full Text] [Related]  

  • 40. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.